Clinical Trials on Ovarian Cancer Recurrent in Finland
Total 1427 results
-
Turku University HospitalActive, not recruitingLocalized Prostate CancerFinland
-
Boneca CorporationCompletedHead and Neck CancerFinland
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
Helsinki University Central HospitalCompletedEarly Breast Cancer | Ambulatory Surgery | Psychosocial WellbeingFinland
-
Mario Negri Institute for Pharmacological ResearchPharmaMar; Averion International CorporationCompletedOvarian CancerAustria, Belgium, Norway, Spain, Finland, United Kingdom, Italy, Denmark, Germany, Netherlands, Switzerland
-
Ferring PharmaceuticalsCompletedInfertility | Polycystic Ovarian SyndromeUnited States
-
Precision TherapeuticsTerminatedCervical Cancer | Uterine Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Peritoneal CancerUnited States
-
NCIC Clinical Trials GroupCompletedOvarian CancerUnited States, Canada, United Kingdom
-
Kuopio University HospitalCompletedRelapse-remitting Multiple SclerosisFinland
-
Turku University HospitalRecruiting
-
Oulu University HospitalActive, not recruiting
-
Unither PharmaceuticalsTerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Agenus Inc.TerminatedGliosarcoma | Recurrent Glioblastoma | Recurrent Adult Brain TumorUnited States
-
Tampere University HospitalCompleted
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
Turku University HospitalRecruitingHead and Neck Squamous Cell CarcinomaFinland
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Endometrial CarcinomaUnited States
-
Helsinki University Central HospitalKarolinska InstitutetRecruitingKidney Cancer | Urothelial Carcinoma | Prostate Carcinoma | Penile Cancer | Testicular CancerFinland
-
Helsinki University Central HospitalInstitute for Molecular MedicineUnknown
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Syros PharmaceuticalsTerminatedBreast Cancer | Ovarian Cancer | Advanced Solid TumorsUnited States, Canada, France
-
Eli Lilly and CompanyCompletedOvarian CancerUnited States, Israel, Spain, Korea, Republic of, Australia, Belgium, United Kingdom, Italy
-
Hoffmann-La RocheCompletedOvarian CancerBelgium, Denmark, France, Germany, Portugal, Spain, Turkey, Bosnia and Herzegovina, Italy, Sweden, Finland, Netherlands, Norway, Greece
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Turku University HospitalCompleted
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Sarcoma | Uterine CarcinosarcomaUnited States
-
Boneca CorporationTerminated
-
University of TurkuHelsinki University Central HospitalCompletedSelf Care | Patient Empowerment | Cancer of Colon | Cancer of Rectum | Patient ActivationFinland
-
Turku University HospitalRecruiting
-
Helsinki University Central HospitalActive, not recruiting
-
Tampere University HospitalTurku University Hospital; Oulu University HospitalTerminated
-
Helsinki University Central HospitalWithdrawnPancreatic Cancer | Biliary StasisFinland
-
NanoBio CorporationCompletedRecurrent Herpes LabialisUnited States
-
Novartis PharmaceuticalsCompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Greece, Canada, Finland, Italy, Spain, United Kingdom, France, Denmark, South Africa, Australia, Poland
-
Aravive, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...TerminatedPlatinum-resistant Ovarian CancerUnited States, Spain, Belgium, Canada, Georgia, Czechia, China, Poland, France, United Kingdom, Italy
-
Finnish Breast Cancer GroupSanofi; Hoffmann-La Roche; AstraZenecaCompleted
-
Menarini GroupTerminatedOvarian CancerUnited States, Spain, Germany, Belgium, France, Czech Republic, Hungary, Italy, Poland
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Endometrial CarcinomaUnited States
-
Tampere University HospitalCompleted
-
University of Eastern FinlandFinnish Cultural Foundation; Academy of Finland; Juho Vainio Foundation; Finnish...Completed
-
BioCis Pharma LtdTurku University Hospital; FinnMedi Oy; Tampere University HospitalCompletedCis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder CancerNon-muscle Invasive Bladder CancerFinland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland
-
Precision TherapeuticsTerminatedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States
-
Oulu University HospitalUnknown
-
Adnexus, A Bristol-Myers Squibb R&D CompanyUnknownBrain and Central Nervous System Tumors | Recurrent Glioblastoma MultiformeUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Sarcoma | Uterine CarcinosarcomaUnited States
-
BicycleTx LimitedRecruitingHead and Neck Cancer | Ovarian Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced Solid Tumor Historically Known for High EphA2 Expression | Urothelial Cancer | Gastric/Upper Gastrointestinal CancerUnited States, Belgium, Korea, Republic of, Spain, United Kingdom
-
Tampere University HospitalRecruiting
-
Turku University HospitalCompletedProstate CancerFinland
-
AstraZenecaCompleted